Advent Life Sciences Fund II LP is a private equity fund based in London, United Kingdom. According to its most recent Form D, filed Nov 3, 2014, it has sold $226,271,136 of interests to 15 investors since its first sale in Sep 2014. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Kaasim Mahmood; Advent LS II LP; Rajesh Parekh.
- Total raised
- $226,271,136Cumulative sales reported on Form D
- Investors
- 15
- First sale
- Sep 9, 2014
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Kaasim Mahmood; Advent LS II LP; Rajesh Parekh
- Latest Form D
- Nov 3, 2014
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Advent Life Sciences Fund II LP
What is the minimum investment for Advent Life Sciences Fund II LP?
Advent Life Sciences Fund II LP's latest Form D, filed Nov 3, 2014, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Advent Life Sciences Fund II LP?
Advent Life Sciences Fund II LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Advent Life Sciences Fund II LP raised?
Advent Life Sciences Fund II LP reports $226,271,136 sold from 15 investors on its Form D filed Nov 3, 2014. This is cumulative sales since the offering began, not current assets or performance.
Where is Advent Life Sciences Fund II LP based?
Advent Life Sciences Fund II LP is based in London, United Kingdom.
When did Advent Life Sciences Fund II LP launch?
Advent Life Sciences Fund II LP reports its first sale in Sep 2014.
Size compared with every private equity fund
Raised more than 91% of the 86 private equity funds based in United Kingdom, and more than 82% of all 8,950 that report sales.